Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...

Oncology Research Program (ORP) today announced new funding for advancing clinical research in Non-Small Cell Lung Cancers ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

Former UFC fighter Ben Askren is recovering from a double lung transplant after weeks awaiting a donor, his wife said on ...